Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
SUPPLEMENT NO. 2 TO PROXY STATEMENT
JUNE 8, 2018
This supplement to proxy statement, dated June 8, 2018 (which we refer to as this supplement), is a supplement to the
proxy statement, dated May 11, 2018, as amended by the supplement, dated May 30, 2018 (which we refer to collectively as the proxy statement), and first mailed to stockholders on or about May 15, 2018, which is the proxy statement of
A. Schulman, Inc. (which we refer to as A. Schulman) for the special meeting of stockholders, scheduled to be held on June 14, 2018, at 11:00 a.m. (ET), at the Sheraton Suites Akron Cuyahoga Falls, 1989 Front Street, Cuyahoga Falls, Ohio 44221,
related to the proposed acquisition (which we refer to as the transaction) of A. Schulman by LyondellBasell Industries N.V. (which we refer to as LyondellBasell). This supplement contains important supplemental information to the proxy statement and
should be read in conjunction with the proxy statement. This supplement does not change the proposals to be considered at the special meeting, which are described in proxy statement. Terms used and not defined in this supplement have the respective
meanings ascribed to such terms in the proxy statement.
Update on Regulatory Approvals Required for the Merger
On May 21, 2018, the State Administration for Market Regulation (SAMR) of the Peoples Republic of China cleared the transaction.
The Committee on Foreign Investment in the United States (CFIUS) accepted the previously disclosed voluntary CFIUS notice filed jointly by A.
Schulman and LyondellBasell.
On June 7, 2018, Mexicos Federal Economic Competition Commission (COFECE) also cleared the
transaction.
As of the date of this supplement, the outstanding regulatory approvals are the European Union, Russia and CFIUS. A. Schulman currently
expects the merger to close in the third calendar quarter of 2018.
Cautionary Statement Regarding Forward-Looking Statements
This supplement to the proxy statement on Schedule 14A is made in reliance upon the safe harbor of the Private Securities Litigation Reform Act of 1995,
including, without limitation, the statements made concerning A. Schulmans intent to consummate the merger with LyondellBasell. As a general matter, forward-looking statements are those focused upon anticipated events or trends, expectations,
and beliefs relating to matters that are not historical in nature. Forward-looking statements can be identified by the fact that they do not relate strictly to historic or current facts and relate to future events and expectations. Forward-looking
statements contain such words as anticipate, estimate, expect, project, intend, plan, believe, forecast, foresee, likely,
may, should, goal, target, might, will, could, predict, continue, and other words and terms of similar meaning in connection with any
discussion of future operating or financial performance. Such forward-looking statements are subject to uncertainties and factors relating to A. Schulmans operations and business environment, all of which are difficult to predict and many of
which are beyond the control of A. Schulman. Among others, the following uncertainties and other factors could cause actual results to differ from those set forth in the forward-looking statements: (i) the risk that the merger may not be
consummated in a timely manner, if at all; (ii) the risk that the definitive merger agreement may be terminated in circumstances that require A. Schulman to pay LyondellBasell a termination fee of $50 million; (iii) risks related to
the diversion of managements attention from A. Schulmans ongoing business operations; (iv) the effect of the announcement of the merger on A.
Schulmans business relationships (including, without limitation, customers and suppliers), operating results and business generally; (v) risks related to obtaining the requisite
consents to the merger, including, without limitation, the receipt of approval from A. Schulmans stockholders, the timing (including possible delays) and receipt of regulatory clearance and CFIUS approval from governmental authorities
(including any conditions, limitations or restrictions placed on these approvals) and the risk that one or more governmental authority may deny any such approval; and (vi) the conditions of the capital markets during the period covered by the
forward-looking statements. Further risks that could cause actual results to differ materially from those matters expressed in or implied by such forward-looking statements are set forth under Risk Factors in A. Schulmans Annual
Report on Form
10-K
for the fiscal year ended August 31, 2017, its subsequent quarterly reports on Form
10-Q
and in A. Schulmans definitive proxy statement,
dated May 11, 2018, that A. Schulman filed with the United States Securities and Exchange Commission (the SEC) in connection with the proposed merger. The list of factors presented here is, and the list of factors presented in A.
Schulmans other SEC filings should not be considered to be a complete statement of all potential risks and uncertainties. In addition, risks and uncertainties not presently known to A. Schulman or that it believes to be immaterial also may
adversely affect A. Schulman. Should any known or unknown risks or uncertainties develop into actual events, or underlying assumptions prove inaccurate, these developments could have material adverse effects on A. Schulmans business, financial
condition and results of operations. A. Schulman does not undertake, and hereby disclaims, any duty to update these forward-looking statements, although its situation and circumstances may change in the future. Persons reading this communication are
cautioned not to place undue reliance on these forward-looking statements which speak only as of the date hereof.
The merger is subject to certain
conditions precedent, including regulatory approvals, CFIUS approval and approval from A. Schulmans stockholders. A. Schulman cannot provide any assurance that the proposed merger will be completed, nor can it give assurances as to the terms
on which such merger will be consummated.
Neither the SEC nor any state securities regulatory agency has approved or disapproved of the
transactions described in this supplement or the proxy statement, including the merger, or determined if the information contained in this supplement or the proxy statement is accurate or adequate. Any representation to the contrary is a criminal
offense.